/ABSI

Absci Corp

ABSI

$8.21USD↓-0.36%-0.03 today

MARKET CAP

1.4B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$8 – $9

52W RANGE

$2

$12

AI Summary

Stalk

Sell NowMedium

ABSI is in a Stage 3 distribution with price below the 9-, 20-, and 50-day moving averages, reinforced by a Bearish Pivot Point and lower highs/lows continuation. Medium-term bias is bearish, with tradability on rallies into the EMA/SMA resistance zone, and short-term weakness confirms a Sell Now posture targeting rejections at this region.

↑ABS-201 Phase 2 trial for endometriosis launches after promising Phase 1 safety data
↑AI-driven platform aligns with projected $8.5B AI in drug-discovery market by 2030
↓Q2 revenue of $0.3M vs. net loss of $33.2M underscores heavy cash burn

Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	12.18 M	141.11 M	+920.11 K	+317.9%	0.00%
WP Woodline Partners LP Q2 2026	SELL	2.70 M	31.30 M	+-3.90 M	+58.1%	0.10%
VI Voloridge Investment Management, LLC Q2 2026	BUYNEW	1.60 M	18.58 M	+1.60 M	+0.0%	0.08%
AC Aqr Capital Management LLC Q2 2026	BUY	756.54 K	8.77 M	+57.10 K	+317.9%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	543.08 K	6.29 M	+-56.35 K	+250.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	359.09 K	4.16 M	+-686.11 K	+32.7%	0.01%
MM Millennium Management LLC Q2 2026	SELL	248.70 K	2.88 M	+-948.67 K	-19.8%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	227.92 K	2.64 M	+227.92 K	+0.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	164.34 K	1.87 M	+-2.25 K	+305.7%	0.00%
MG Man Group Plc Q2 2026	BUY	85.27 K	988.31 K	+25.51 K	+451.3%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	42.77 K	495.66 K	+42.77 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	9.35 K	108.38 K	+7.19 K	+1571.0%	0.00%